Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...
Kimberly-Clark said the combination would create a company with $32 billion in revenue and allow it to surpass Unilever Plc ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
The S&P 500 and Nasdaq kicked off November on firmer ground on Monday, after a slew of AI deals boosted megacap companies Amazon and Nvidia, while Kenvue shares soared after Kimberly-Clark's buyout ...
Dow Jones Top Company Headlines at 11 PM ET: The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker | Palantir ... Mike Hsu aims to stoke the consumer company's growth by veering into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback